Oncology LibraryOncology Library Facebook ad: “Would this change your practice?”
Ran for 43 days, from July 7 to August 19, 2026, the last day Crush saw it.
Run by Oncology Library on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 26839886605689522
- Platforms
- Facebook, Instagram, Messenger and Threads
- Relaunches
- 0
- EU reach
- 24,954
- Niche
- Sports & Training
Ad text
Would this change your practice? The 2026 MSKCC Update in Hematology and Medical Oncology — 47 faculty-led sessions covering the practice-changing data of the last two years: — Blinatumab in MRD-neg CR · 58% lower risk of death (E1910) — Asciminib as first-line CML (ASC4FIRST) — Obe-cel with lower CRS/ICANS (FELIX) — Ph+ ALL without transplant ~$3,500 → $189. Lifetime access. 30-day money back. 👉 onclibrary.com
Where the ad sends people
onclibrary.com
Oncology Library
Get offer view: onclibrary.com(opens in a new tab)
